[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369777-105":59,"doc-detail-369777-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-analysis-of-human-colorectal-cancers-harboring-polymerase-epsilon-mutations","Comprehensive Analysis of Human Colorectal Cancers Harboring Polymerase Epsilon Mutations","","DNA polymerase epsilon (POLe) is the main leading-strand replicative polymerase, and mutations in its proofreading domain generate replication errors that raise mutational burden in cancer cells, supporting its role as a cancer driver gene. The study applies an artificial intelligence algorithm to identify co-occurring mutations with POLe variants in colorectal cancers, grouping POLe alterations into driver, passenger, and WT. Results show that driver POLe mutations do not strongly associate with driver mutations in other genes, and structural analysis implicates disrupted Mg2+ coordination in the active site. Overall, colorectal cancer mutational accumulation reflects complex, multifactorial processes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-analysis-of-human-colorectal-cancers-harboring-polymerase-epsilon-mutations/369777/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-human-colorectal-cancers-harboring-polymerase-epsilon-mutations/369777.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do polymerase epsilon (POLe) proofreading-domain mutations play in colorectal cancer?","Question",{"text":112,"@type":113},"Proofreading-domain POLe mutations increase replication errors and mutational burden, which supports POLe as a cancer driver gene. This can contribute to large numbers of gene mutations in cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study identify co-occurring mutations with POLe mutations?",{"text":117,"@type":113},"It uses an artificial intelligence algorithm to analyze colorectal cancers, partitioning POLe mutations into driver, passenger, and WT (no mutation). Then it assesses mutations in other genes across these groups.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the findings suggest about driver mutations and POLe?",{"text":121,"@type":113},"A driver POLe mutation is not likely to associate with driver mutations in other genes, implying colorectal cancer driver mutations may purify independently of POLe. Mutations affecting POLe function also do not necessarily increase the frequency of driver mutations elsewhere.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369777,1790218868,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nComprehensive Analysis of Human Colorectal Cancers Harboring Polymerase Epsilon Mutations  \nLouis M. Gibson 1,2,†, Phanithan Konda 3,†, Hunter J. Bliss 4, Devi D. Nelakurti 2,5, Golrokh Mirzaei 6, Renee A. Bouley 7, Jing J. Wang 8,* and Ruben C. Petreaca 2,9, *  \nAcademic Editor: Keeley Brookes  \nReceived: 27 June 2025  \nRevised: 17 July 2025  \nAccepted: 22 July 2025  \nPublished: 25 July 2025  \nCitation: Gibson, L.M.; Konda, P.; Bliss, H.J.; Nelakurti, D.D.; Mirzaei, G.; Bouley, R.A.; Wang, J.J.; Petreaca, R.C. Comprehensive Analysis of Human Colorectal Cancers Harboring Polymerase Epsilon Mutations. Int. J. Mol. Sci. 2025, 26, 7208. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26157208](doi.org/10.3390/ijms26157208)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Neuroscience Undergraduate Program, The Ohio State University, Columbus, OH 43210, USA; [lgibson1224@outlook.com](lgibson1224@outlook.com)  \n2 The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; [devidheekshita.nelakurti@osumc.edu](devidheekshita.nelakurti@osumc.edu)  \n3 College Credit Plus Program, The Ohio State University, Columbus, OH 43210, USA  \n4 Biology Undergraduate Program, The Ohio State University, Marion, OH 43302, USA; [bliss.92@buckeyemail.osu.edu](bliss.92@buckeyemail.osu.edu)  \n5 Biomedical Science Undergraduate Program, The Ohio State University College of Medicine, Columbus, OH 43210, USA  \n6 Department of Computer Science and Engineering, The Ohio State University, Marion, OH 43302, USA; [mirzaei.4@osu.edu](mirzaei.4@osu.edu)  \n7 Department of Chemistry and Biochemistry, The Ohio State University, Marion, OH 43302, USA; [bouley.8@osu.edu](bouley.8@osu.edu)  \n8 Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA  \n9 Department of Molecular Genetics, The Ohio State University, Marion, OH 43302, USA  \n* [Correspondence: jing.wang@osumc.edu](Correspondence: jing.wang@osumc.edu) (J.J.W.); [petreaca.1@osu.edu](petreaca.1@osu.edu) (R.C.P.)† These authors contributed equally to this work.  \nAbstract  \nDNA polymerase epsilon (POLe) is the leading strand replicative polymerase. POLe mutations located primarily in the proofreading domain cause replication errors and increase mutation burden in cancer cells. Consequently, POLe has been classified as a cancer driver gene. Certain POLe frameshift mutations that affect the proofreading domain are purified in cancer cells, but point mutations in other domains have also been reported. Here we use an artificial intelligence algorithm to determine what other mutations cooccur with POLe mutations in colorectal cancers. We partitioned POLe mutations into driver, passenger, and WT (no mutation), then assessed mutations in other genes in these three groups. We found that a driver POLe mutation is not likely to associate with driver mutations in other genes. Thus, driver mutations in colorectal cancers appear to purify in a manner that is independent of POLe. Mutations that affect POLe function do not necessarily increase the frequency of driver mutations in other genes. Structural analysis shows that many POLe driver mutations affect coordination of the Mg2+ ion in the active site. Our data show that the accumulation of colorectal cancer mutations is driven by complex factors.  \nKeywords: colorectal cancer; polymerase epsilon; driver mutation  \n1. Introduction  \nColorectal cancer (CRC) is the third most common cancer and second leading cause of cancer mortality in the US, with the majority of deaths from metastatic disease. While the 5-year survival rate for ","cbCaialq3Qdv2ryR","https://ap.wps.com/l/cbCaialq3Qdv2ryR","pdf",18327554,14,"English","# Abstract\n# Introduction\n## Colorectal cancer overview and survival\n## Genome instability and CRC molecular subgroups","[{\"question\":\"What role do polymerase epsilon (POLe) proofreading-domain mutations play in colorectal cancer?\",\"answer\":\"Proofreading-domain POLe mutations increase replication errors and mutational burden, which supports POLe as a cancer driver gene. This can contribute to large numbers of gene mutations in cancer cells.\"},{\"question\":\"How does the study identify co-occurring mutations with POLe mutations?\",\"answer\":\"It uses an artificial intelligence algorithm to analyze colorectal cancers, partitioning POLe mutations into driver, passenger, and WT (no mutation). Then it assesses mutations in other genes across these groups.\"},{\"question\":\"What do the findings suggest about driver mutations and POLe?\",\"answer\":\"A driver POLe mutation is not likely to associate with driver mutations in other genes, implying colorectal cancer driver mutations may purify independently of POLe. Mutations affecting POLe function also do not necessarily increase the frequency of driver mutations elsewhere.\"}]","Comprehensive Analysis of Human Colorectal Cancers Harboring Polymerase Epsilon Mutations | PDF",1790184496,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/836d8e8f1229a7f8fa314b68174da12d.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8a65edfbd20a7e9fd57423ad4dc4a8a.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/397e56ec3087658f7d33a7af0c57eda4.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16520da4749e83b885ce8e61c60eb669.webp",980,1385]